Product: | Leuprolide Acetate | |
---|---|---|
Catalog Number: | 17541 | |
CAS Number: | 74381-53-6 | |
Synonyms: |
Leuprolide Acetate salt; des-Gly10-[D-Leu6]-LH-RH ethylamide |
|
Pricing: |
|
|
Formula: | C59H84N16O12 • xC2H4O2 | |
Chemical Purity: | >98% | |
Molecular Weight: | 1209.40 | |
Structure: |
![]() |
|
Appearance: | White powder | |
Category: | Anti-cancer compounds | |
Stability: | Stable under recommended storage conditions | |
Storage: |
Keep container tightly closed in a dry and well-ventilated place. Recommended storage temperature: -20°C. |
|
Transportation: |
Non-hazardous for transport |
|
Literature References: |
Zheng, Y, et al., Permeability and absorption of leuprolide from various intestinal regions in rabbits and rats. Int. J. Pharmacol. 185, 83, (1999); Goto, T., et al., Gonadotropin-releasing hormone agonist has the ability to induce increased matrix metalloproteinase (MMP)-2 and membrane type 1-MMP expression in corpora lutea, and structural luteolysis in rats. J. Endocrinol. 161, 393-402, (1999); Ogawa, T., et al., Leuprolide, a gonadotropin-releasing hormone agonist, enhances colonization after spermatogonial transplantation into mouse testes. Cell 30, 583-588, (1998); Ravivarapu, H.B., et al., Sustained suppression of pituitary-gonadal axis with an injectable, in situ forming implant of leuprolide acetate. J. Pharm. Sci. 89, 732-741, (2000); Imai, A., et al., Fas and Fas ligand system may mediate antiproliferative activity of gonadotropin-releasing hormone receptor in endometrial cancer cells. Int. J. Oncol. 13, 97-100, (1998); Merck 14,5457 |
|
MSDS: | ||
Description: |
Luteinizing hormone releasing hormone (LH-RH) agonist. |